Third Arc Bio teams up with Adagene to create T-cell engagers
13 Nov 2025 //
GLOBENEWSWIRE
Third Arc Bio Begins Phase 1 Trial of ARC101 for CLDN6 Cancers
13 Mar 2025 //
PR NEWSWIRE
J&J vets burst into biotech with $165M Third Arc series A
23 Jul 2024 //
FIERCE BIOTECH

Market Place
Sourcing Support